89 related articles for article (PubMed ID: 27130545)
1. High-dose green tea polyphenol intake decreases CYP3A expression in a liver-specific manner with increases in blood substrate drug concentrations.
Ikarashi N; Ogawa S; Hirobe R; Kusunoki Y; Kon R; Ochiai W; Sugiyama K
Eur J Pharm Sci; 2016 Jun; 89():137-45. PubMed ID: 27130545
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora.
Ikarashi N; Ogawa S; Hirobe R; Kon R; Kusunoki Y; Yamashita M; Mizukami N; Kaneko M; Wakui N; Machida Y; Sugiyama K
Eur J Pharm Sci; 2017 Mar; 100():211-218. PubMed ID: 28115221
[TBL] [Abstract][Full Text] [Related]
3. Total gastrectomy may result in reduced drug effectiveness due to an increase in the expression of the drug-metabolizing enzyme Cytochrome P450, in the liver.
Ishii M; Toda T; Ikarashi N; Kusunoki Y; Kon R; Ochiai W; Machida Y; Sugiyama K
Eur J Pharm Sci; 2014 Jan; 51():180-8. PubMed ID: 24095864
[TBL] [Abstract][Full Text] [Related]
4. Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis.
Kusunoki Y; Ikarashi N; Hayakawa Y; Ishii M; Kon R; Ochiai W; Machida Y; Sugiyama K
Eur J Pharm Sci; 2014 Apr; 54():17-27. PubMed ID: 24413062
[TBL] [Abstract][Full Text] [Related]
5. Effects of menthol on the pharmacokinetics of triazolam and phenytoin.
Hoshino M; Ikarashi N; Hirobe R; Hayashi M; Hiraoka H; Yokobori K; Ochiai T; Kusunoki Y; Kon R; Tajima M; Ochiai W; Sugiyama K
Biol Pharm Bull; 2015; 38(3):454-60. PubMed ID: 25757928
[TBL] [Abstract][Full Text] [Related]
6. Different diets cause alterations in the enteric environment and trigger changes in the expression of hepatic cytochrome P450 3A, a drug-metabolizing enzyme.
Tajima M; Ikarashi N; Igeta S; Toda T; Ishii M; Tanaka Y; Machida Y; Ochiai W; Yamada H; Sugiyama K
Biol Pharm Bull; 2013; 36(4):624-34. PubMed ID: 23370405
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the hepatic metabolism of triazolam in wild-type andCyp3a-knockout mice for understanding CYP3A-mediated metabolism inCYP3A-humanised mice
Minegishi G; Kazuki Y; Yamasaki Y; Okuya F; Akita H; Oshimura M; Kobayashi K
Xenobiotica; 2019 Nov; 49(11):1303-1310. PubMed ID: 30561249
[TBL] [Abstract][Full Text] [Related]
8. The guinea-pig expresses functional CYP2C and P-glycoprotein: further validation of its usefulness in drug biotransformation/transport studies.
Hasibu I; Patoine D; Pilote S; Drolet B; Simard C
Biopharm Drug Dispos; 2015 Apr; 36(3):183-203. PubMed ID: 25472529
[TBL] [Abstract][Full Text] [Related]
9. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
Matheny CJ; Ali RY; Yang X; Pollack GM
Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
11. Short communication: insulin alters hepatic progesterone catabolic enzymes cytochrome P450 2C and 3A in dairy cows.
Lemley CO; Butler ST; Butler WR; Wilson ME
J Dairy Sci; 2008 Feb; 91(2):641-5. PubMed ID: 18218751
[TBL] [Abstract][Full Text] [Related]
12. Effect of commercially available green and black tea beverages on drug-metabolizing enzymes and oxidative stress in Wistar rats.
Yao HT; Hsu YR; Lii CK; Lin AH; Chang KH; Yang HT
Food Chem Toxicol; 2014 Aug; 70():120-7. PubMed ID: 24815822
[TBL] [Abstract][Full Text] [Related]
13. Consumption of a high-fat diet during pregnancy decreases the activity of cytochrome P450 3a in the livers of offspring.
Tajima M; Ikarashi N; Imahori Y; Okaniwa T; Saruta K; Ishii M; Kusunoki Y; Kon R; Toda T; Ochiai W; Yamada H; Sugiyama K
Eur J Pharm Sci; 2012 Aug; 47(1):108-16. PubMed ID: 22659374
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs.
van Beusekom CD; Schipper L; Fink-Gremmels J
J Vet Pharmacol Ther; 2010 Dec; 33(6):519-27. PubMed ID: 21062303
[TBL] [Abstract][Full Text] [Related]
15. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.
Zhang W; Tan TM; Lim LY
Drug Metab Dispos; 2007 Jan; 35(1):110-5. PubMed ID: 17050652
[TBL] [Abstract][Full Text] [Related]
16. Differences in the pharmacokinetics of Cyp3a substrates in TSOD and streptozotocin-induced diabetic mice.
Kudo T; Toda T; Ushiki T; Ohi K; Ikarashi N; Ochiai W; Sugiyama K
Xenobiotica; 2010 Apr; 40(4):282-90. PubMed ID: 20163193
[TBL] [Abstract][Full Text] [Related]
17. Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity.
Kostrubsky VE; Szakacs JG; Jeffery EH; Wood SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
Toxicol Appl Pharmacol; 1997 Apr; 143(2):315-23. PubMed ID: 9144448
[TBL] [Abstract][Full Text] [Related]
18. Consumption of a high-fat diet during pregnancy changes the expression of cytochrome P450 in the livers of infant male mice.
Tajima M; Ikarashi N; Okaniwa T; Imahori Y; Saruta K; Toda T; Ishii M; Tanaka Y; Machida Y; Ochiai W; Yamada H; Sugiyama K
Biol Pharm Bull; 2013; 36(4):649-57. PubMed ID: 23358370
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
20. Liver lobe and strain differences in the activity of murine cytochrome P450 enzymes.
Rudeck J; Bert B; Marx-Stoelting P; Schönfelder G; Vogl S
Toxicology; 2018 Jul; 404-405():76-85. PubMed ID: 29879457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
